Eisai currently works across Europe in the areas of Alzheimer’s disease, gastro-intestinal disorders, epilepsy, cervical dystonia, severe chronic pain and oncology.

Product Overview

Click on the brand name below for further information and related links

Fycompa

perampanel

For the treatment of  patients aged 12 years and older with partial onset seizures

Click here to view Halvalen product details

Halaven

eribulin mesylate

For the treatment of locally advanced or metastatic breast cancer

Click here to view Halvalen product details

Zonegran

zonisamide

For the treatment of adult patients with partial-onset seizures

Click here

Zebinix

eslicarbazepine acetate

For the treatment of adult patients with partial-onset seizures

Click here to view Zebinix product details

Inovelon

rufinamide

For the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS)

Click here to view Inovelon product details

Prialt

ziconotide

For the treatment of severe, chronic pain

Click here to view Prialt product details

NeuroBloc

botulinum toxin type B

For the treatment of cervical dystonia (torticollis)

Click here to view NeuroBlock product details

Aricept

donepezil hydrochloride

For the treatment of Alzheimer's disease

Click here to view Aricpet product details

Pariet

rabeprazole sodium

For the treatment of gastric acid-related disorders

Click here to view Pariet product details

 

Understanding the future information for investors